The U.S. Food and Drug Administration has announced the recall of nearly one million bottles of two prescription medications used to treat heart failure and kidney-related conditions.
California-based Amgen Inc. voluntarily recalled more than 934,000 bottles of Corlanor, also known by its generic name ivabradine, after foreign material was found on tablets in certain lots. The recall includes 5-milligram, 14-count bottles and some 7.5-milligram, 60-count bottles.
Corlanor is prescribed to reduce the risk of hospitalization for patients with worsening heart failure.
The company also recalled more than 9,500 bottles of Sensipar, or cinacalcet, after identifying manufacturing quality issues. Sensipar is used to treat certain patients with chronic kidney disease and conditions that cause elevated calcium levels.
The recalled Sensipar includes 30-, 60- and 90-milligram tablets.
According to the California State Board of Pharmacy, health officials have determined the recalls present a low risk to patient safety. The affected medications were distributed between October 2021 and December 2025.
Patients with questions about their medication should contact their pharmacist or healthcare provider before stopping any prescribed treatment.